Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Adcon L

Drug Profile

Adcon L

Alternative Names: Adcon-L; Adocon-L; GL-402; GT-402

Latest Information Update: 15 Oct 2009

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Wright Medical Group
  • Developer Wright Medical Group; Wright Medical Japan; Wright Medical Technology
  • Class Organic chemicals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Epidural fibrosis; Post-surgical adhesions

Most Recent Events

  • 14 Mar 2003 Gliatech's Adcon® Gel technology has been purchased by Wright Medical Group Inc.
  • 01 Nov 2002 The US FDA is resuming scientific review of Gliatech's applications
  • 26 Sep 2002 Gliatech is auctioning its Adcon® assets
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top